XNYS
KRO
Market cap676mUSD
Jul 09, Last price
5.90USD
1D
0.34%
1Q
-10.74%
Jan 2017
-50.59%
IPO
-31.40%
Name
Kronos Worldwide Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kronos Worldwide, Inc. stands as a prominent global producer and supplier of titanium dioxide (TiO2) pigments, with operations spanning Europe, North America, the Asia Pacific, and other international territories. The company manufactures TiO2 in both its rutile and anatase crystalline structures, which are essential for contributing whiteness, brilliance, opacity, and resilience to a broad spectrum of goods. This includes everyday items such as paints, coatings, plastics, paper, fibers, and ceramics, alongside specialized applications in inks, food products, and cosmetics. In addition to its primary TiO2 business, Kronos also processes ilmenite, a foundational raw material crucial for sulfate-process TiO2 manufacturing facilities. Its diverse product portfolio further encompasses iron-based chemicals, which are indispensable for treating and conditioning industrial and municipal wastewater, as well as for use in producing iron pigments, cement, and various agricultural solutions. The firm also develops specialized chemicals utilized in crafting pearlescent pigments, fabricating electroceramic capacitors for mobile phones and other electronic gadgets, and for various specific industrial purposes, including natural gas piping. The company extends technical support and services for its entire product range. Its KRONOS-branded offerings are distributed to manufacturers of paints, plastics, decorative laminates, and paper via an extensive network of agents and distributors. Founded in 1916, Kronos Worldwide, Inc. maintains its corporate headquarters in Dallas, Texas, and operates as a subsidiary of Valhi, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||